Daniel Larcombe-Young
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 8
- CAR-T cell therapy research 8
-
- Toxin Mechanisms and Immunotoxins 1
- Immunotherapy and Immune Responses 1
- Co-authors
- David Marc Davies (6 shared papers)John F. Maher (6 shared papers)James W. Opzoomer (1 shared paper)Cheryl L. Scudamore (1 shared paper)Natalie L. Woodman (1 shared paper)Tamara Muliaditan (1 shared paper)Paris Kosti (1 shared paper)James N. Arnold (1 shared paper)
- Journals
- Cell Reports Medicine (3 papers)Clinical Cancer Research (1 paper)Frontiers in Immunology (1 paper)Molecular Therapy (1 paper)Biology (1 paper)
- Partner nations
- United KingdomItalySaudi Arabia
In The Last Decade
Daniel Larcombe-Young
10 papers receiving 352 citations
Peers
Comparison fields: 5 of 31
- Oncology 237
- Immunology 50
- Cancer Research 25
- Radiology, Nuclear Medicine and Imaging 31
- Biomaterials 17
Countries citing papers authored by Daniel Larcombe-Young
This map shows the geographic impact of Daniel Larcombe-Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Larcombe-Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Larcombe-Young more than expected).
Fields of papers citing papers by Daniel Larcombe-Young
This network shows the impact of papers produced by Daniel Larcombe-Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Larcombe-Young. The network helps show where Daniel Larcombe-Young may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Larcombe-Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 126 | |
| 2 | 2018 | 80 | |
| 3 | 2021 | 51 | |
| 4 | 2024 | 28 | |
| 5 | 2022 | 24 | |
| 6 | 2020 | 19 | |
| 7 | 2024 | 17 | |
| 8 | 2022 | 3 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 3 |
About Daniel Larcombe-Young
Daniel Larcombe-Young is a scholar working on Oncology, Immunology, Cancer Research, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 354 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Breast Cancer Treatment Studies (1 paper), Folate and B Vitamins Research (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Immunotherapy and Immune Responses (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Oncology (237 citations), Immunology (50 citations), Cancer Research (25 citations), Radiology, Nuclear Medicine and Imaging (31 citations) and Biomaterials (17 citations). Daniel Larcombe-Young has collaborated with scholars based in United Kingdom, Italy and Saudi Arabia. Frequent co-authors include David Marc Davies, John F. Maher, James W. Opzoomer, Cheryl L. Scudamore, Natalie L. Woodman, Tamara Muliaditan, Paris Kosti, James N. Arnold, Selvam Thavaraj and Rhonda Henley‐Smith. Their work appears in journals such as Cell Reports Medicine, Clinical Cancer Research, Frontiers in Immunology, Molecular Therapy and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.